Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI64369

Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke–induced emphysema in mice

Matthias Clauss, Robert Voswinckel, Gangaraju Rajashekhar, Ninotchka L. Sigua, Heinz Fehrenbach, Natalia I. Rush, Kelly S. Schweitzer, Ali Ö. Yildirim, Krzysztof Kamocki, Amanda J. Fisher, Yuan Gu, Bilal Safadi, Sandeep Nikam, Walter C. Hubbard, Rubin M. Tuder, Homer L. Twigg III, Robert G. Presson, Sanjay Sethi, and Irina Petrache

Find articles by Clauss, M. in: PubMed | Google Scholar

Find articles by Voswinckel, R. in: PubMed | Google Scholar

Find articles by Rajashekhar, G. in: PubMed | Google Scholar

Find articles by Sigua, N. in: PubMed | Google Scholar

Find articles by Fehrenbach, H. in: PubMed | Google Scholar

Find articles by Rush, N. in: PubMed | Google Scholar

Find articles by Schweitzer, K. in: PubMed | Google Scholar

Find articles by Yildirim, A. in: PubMed | Google Scholar

Find articles by Kamocki, K. in: PubMed | Google Scholar

Find articles by Fisher, A. in: PubMed | Google Scholar

Find articles by Gu, Y. in: PubMed | Google Scholar

Find articles by Safadi, B. in: PubMed | Google Scholar

Find articles by Nikam, S. in: PubMed | Google Scholar

Find articles by Hubbard, W. in: PubMed | Google Scholar

Find articles by Tuder, R. in: PubMed | Google Scholar

Find articles by Twigg, H. in: PubMed | Google Scholar

Find articles by Presson, R. in: PubMed | Google Scholar

Find articles by Sethi, S. in: PubMed | Google Scholar

Find articles by Petrache, I. in: PubMed | Google Scholar

Published July 2, 2012 - More info

Published in Volume 122, Issue 7 on July 2, 2012
J Clin Invest. 2012;122(7):2703–2703. https://doi.org/10.1172/JCI64369.
© 2012 The American Society for Clinical Investigation
Published July 2, 2012 - Version history
View PDF

Related article:

Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke–induced emphysema in mice
Matthias Clauss, … , Sanjay Sethi, Irina Petrache
Matthias Clauss, … , Sanjay Sethi, Irina Petrache
Research Article Pulmonology

Lung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke–induced emphysema in mice

  • Text
  • PDF
Abstract

Pulmonary emphysema is a disease characterized by alveolar cellular loss and inflammation. Recently, excessive apoptosis of structural alveolar cells has emerged as a major mechanism in the development of emphysema. Here, we investigated the proapoptotic and monocyte chemoattractant cytokine endothelial monocyte-activating protein 2 (EMAPII). Lung-specific overexpression of EMAPII in mice caused simplification of alveolar structures, apoptosis, and macrophage accumulation, compared with that in control transgenic mice. Additionally, in a mouse model of cigarette smoke–induced (CS-induced) emphysema, EMAPII levels were significantly increased in murine lungs. This upregulation was necessary for emphysema development, as neutralizing antibodies to EMAPII resulted in reduced alveolar cell apoptosis, inflammation, and emphysema-associated structural changes in alveoli and small airways and improved lung function. The mechanism of EMAPII upregulation involved an apoptosis-dependent feed-forward loop, since caspase-3 instillation in the lung markedly increased EMAPII expression, while caspase inhibition decreased its production, even in transgenic EMAPII mice. These findings may have clinical significance, as both current smokers and ex-smoker chronic obstructive pulmonary disease (COPD) patients had increased levels of secreted EMAPII in the bronchoalveolar lavage fluid compared with that of nonsmokers. In conclusion, we suggest that EMAPII perpetuates the mechanism of CS-induced lung emphysema in mice and, given its secretory nature, is a suitable target for neutralization antibody therapy.

Authors

Matthias Clauss, Robert Voswinckel, Gangaraju Rajashekhar, Ninotchka L. Sigua, Heinz Fehrenbach, Natalia I. Rush, Kelly S. Schweitzer, Ali Ö. Yildirim, Krzysztof Kamocki, Amanda J. Fisher, Yuan Gu, Bilal Safadi, Sandeep Nikam, Walter C. Hubbard, Rubin M. Tuder, Homer L. Twigg III, Robert G. Presson, Sanjay Sethi, Irina Petrache

×

Original citation: J. Clin. Invest. 2011;121(6):2470–2479. doi:10.1172/JCI43881.

Citation for this corrigendum: J. Clin. Invest. 2012;122(7):2703. doi:10.1172/JCI64369.

During the preparation of Figure 2F, the label of the y axis was listed with incorrect units of measurement and without specifying the scale of 10–2. The y axis units should be ml/cm H2O. The correct figure is below.

The authors regret the error.

Version history
  • Version 1 (July 2, 2012): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts